Epsilon Healthcare (ASX:EPN) — Material Events

ASX:EPN · 15 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 10 articles Notable 5 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
10
Epsilon Healthcare Surges 96% in Q4 Receipts, Reinstated on ASXMedium
Epsilon Healthcare Posts Record Q4 Receipts, Reinstated to ASX, Eyes Expansion
28 Jan 2026 ·Quarterly Activities Report and Appendix 4C ·85
Epsilon Healthcare Surges with Record $2.9M Quarter, Cuts Debt Post-AdministrationMedium
Epsilon Healthcare Reports Record Q3 2025 Receipts and Debt Reduction Post-Voluntary Administration
7 Nov 2025 ·Quarterly Activities Report and Appendix 4C ·85
Epsilon Healthcare Posts Record $3.14M Receipts, Accelerates Growth TrajectoryMedium
Epsilon Healthcare Delivers Record $3.14M Quarterly Receipts, 154% YOY Growth
30 Apr 2026 ·Quarterly Activities Report and Appendix 4C ·85
Epsilon Healthcare’s 2025 Turnaround: Revenue Surges, Losses Narrow SharplyMedium
Epsilon Healthcare reports strong revenue growth and reduced loss in 2025, driven by CDMO and new Pharmacy division
27 Feb 2026 ·Preliminary Final Report ·80
Epsilon Healthcare Charts Clear Path to ASX Reinstatement with Solid FinancialsMedium
Epsilon Healthcare prepares for ASX reinstatement with improved financials and strategic growth plan
18 Dec 2025 ·Pre-Reinstatement Disclosure ·80
Epsilon Pharma Secures AU$6M Deal to Manufacture Cannabis Products for UK and EuropeMedium
Epsilon Pharma inks 3-year AU$6M manufacturing deal with Puro NZ for UK and European cannabis market expansion
5 Feb 2026 ·ASX Release ·80
Epsilon Healthcare Surges 73% in Revenue, Eyes Sustained GrowthMedium
Epsilon Healthcare posts 73% revenue growth in June quarter, strengthens financial position
7 Nov 2025 ·Quarterly Activities Report and Appendix 4C ·75
Epsilon Healthcare Boosts Revenue 19% Amid Restructuring but Posts Larger LossMedium
Epsilon Healthcare reports 19% revenue growth but wider net loss; completes $6.7M sale-leaseback and capital raise amid ASX suspension
16 Dec 2025 ·Appendix 4D and Consolidated Interim Financial Report ·75
Epsilon Healthcare Faces $3.25M Loss Amid Voluntary Administration RecoveryHigh
Epsilon Healthcare posts $3.25M loss in 2024 amid voluntary administration recovery
7 Oct 2025 ·Preliminary Final Report ·Unexpected ·75
Epsilon Healthcare Unlocks $6.7M, Cuts Debt with Southport Sale-LeasebackMedium
Epsilon Healthcare completes $6.7m sale and leaseback of Southport facility, reduces debt
29 July 2025 ·ASX Release ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.

Market Mentions 4 - appeared in market wrap coverage